Similar Articles
1191 Massive haemorrhage in liver transplantation: Consequences, prediction and management
1192 Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy
1193 Impact of body mass index on outcomes of 48281 patients undergoing first time cadaveric liver transplantation
1194 Ventilator associated pneumonia following liver transplantation: Etiology, risk factors and outcome
1195 Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience
1196 Proposal of new expanded selection criteria using total tumor size and 18F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria
1197 Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients
1198 Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma
1199 Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments
1200 miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA